Medigene acquires Trianta Immunotherapies

Medigene has acquired the Munich-based company, Trianta Immunotherapies, a spin-off of the Helmholtz Zentrum München. Trianta is developing three highly innovative and complementary immunotherapy platforms with programs in clinical development to treat various tumour types.

DealsNorth AmericaUSBriefs